Sujay Kango News Today

File New Definitive Consent Materials to Remove Entire MEI Pharma Board for Cause and Add Advisory Proposal Requesting the Return of Capital to...

Infinity Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced...

MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors SAN DIEGO, November 23, 2021 - MEI Pharma, Inc. , a late-stage pharmaceutical... | November 23, 2021

MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace

Operator Good afternoon, ladies and gentlemen, and welcome to the Acceleron First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Ms. Jamie Bernard, Associate Director of Investor Relations at Acceleron. Please go ahead. Jamie A. Bernard -- Associate Director of Investor Relations Thanks, and welcome, everyone, to our first quarter 2021 earnings call. The press release reporting our financial results in addition to the presentation for t...